NCT03952468View on ClinicalTrials.gov

Combined TMS and Brief Cognitive Behavioral Therapy to Reduce Suicide

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

November 4, 2019

Primary Completion Date

April 30, 2024

Study Completion Date

April 30, 2024

Conditions
Suicide
Interventions
DEVICE

Transcranial Magnetic Stimulation

Administration of rapidly fluctuating magnetic field, delivered over the dorsolateral prefrontal cortex.

OTHER

Brief Cognitive Behavioral Therapy

BCBT is a well-established and efficacious treatment that is an extension of Cognitive Behavioral Therapy, a treatment that is widely implemented across VA health care systems.

Trial Locations (1)

02908-4734

Providence VA Medical Center, Providence, RI, Providence

All Listed Sponsors
lead

VA Office of Research and Development

FED

NCT03952468 - Combined TMS and Brief Cognitive Behavioral Therapy to Reduce Suicide | Biotech Hunter | Biotech Hunter